Is INFI a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

550 people get INFI articles and Market Currents by email alert.

Get email alerts on INFI »

HEADLINES:

Investing In Cancer Research Is Worth The Risk: Echo He
Life Sciences Report • Fri, May 24
Infinity to Present at Deutsche Bank's 38th Annual Health Care Conference

Business Wire (Wed, 8:00AM)
Insiders And Funds Are Bullish On These 3 Small Cap Healthcare Stocks
Kapitall • Tue, May 21 • 2 Comments
Infinity Announces Clinical Data to Be Presented at ASCO and ICML

Business Wire (May 15, 2013)
Infinity to Present at the UBS Global Healthcare Conference

Business Wire (May 14, 2013)
Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sector
GuruFundPicks • Thu, May 9 • 5 Comments
Infinity Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
Tue, May 7
Infinity Reports First Quarter 2013 Financial Results and Provides Company Update

Business Wire (May 7, 2013)
Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers
GuruFundPicks • Tue, May 7 • 8 Comments
Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers
GuruFundPicks • Sun, May 5 • 3 Comments
Infinity Announces the Date of Its First Quarter 2013 Financial Results Conference Call and Webcast

Business Wire (Apr 24, 2013)
Infinity to Present at the Needham 12th Annual Healthcare Conference

Business Wire (Apr 23, 2013)
Infinity Announces Closing of Secondary Offering of Common Stock and Exercise of Over-Allotment Option

Business Wire (Apr 16, 2013)
Infinity Announces Pricing of Secondary Offering of Common Stock

Business Wire (Apr 11, 2013)
Infinity Announces Proposed Secondary Offering of Common Stock

Business Wire (Apr 9, 2013)
Infinity Pharmaceuticals' Management Presents at Barclays Global Healthcare Conference (Transcript)
Tue, Mar 12 • 1 Comment
Infinity to Present at the 25th Annual Roth Conference

Business Wire (Mar 11, 2013)
Infinity Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Mar 5
Infinity Provides Company Update and Reports Full-Year 2012 Financial Results

Business Wire (Mar 5, 2013)
Why I Strive To Be An Average Investor
Rich Willis • Thu, Feb 28 • 7 Comments

To learn more about Seeking Alpha Pro, click here.

Infinity Pharmaceuticals: Completion Of Phase I/II Trials May Drive Stock
LifeSci Advisors • Tue, Nov 27, 2012

Investing In Cancer Research Is Worth The Risk: Echo He
Life Sciences Report • Fri, May 24
Insiders And Funds Are Bullish On These 3 Small Cap Healthcare Stocks
Kapitall • Tue, May 21 • 2 Comments
Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sector
GuruFundPicks • Thu, May 9 • 5 Comments
Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers
GuruFundPicks • Tue, May 7 • 8 Comments
Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers
GuruFundPicks • Sun, May 5 • 3 Comments
Why I Strive To Be An Average Investor
Rich Willis • Thu, Feb 28 • 7 Comments
Don't Tune Out; Pharmacyclics' Move Higher Isn't Over Yet
PropThink • Thu, Feb 21 • 2 Comments
Insider Buying Trends: Are These Cash Rich Companies Ready To Rally?
Kapitall • Tue, Feb 5
5 Highly Shorted Stocks Being Bought By Insiders
Kapitall • Fri, Jan 25 • 4 Comments
2 Highly Shorted Stocks With Strong Institutional And Insider Buying
Kapitall • Fri, Jan 18 • 1 Comment
4 Rallying Biotech Stocks Being Snapped Up By Insiders
Kapitall • Wed, Jan 16 • 2 Comments
TG Therapeutics: Biotech Suitors Not Waiting For Clinical Results
George Brooks • Mon, Jan 14 • 3 Comments
These Stocks Are On Winning Streaks, But Short Sellers Aren't Optimistic
Kapitall • Wed, Jan 9 • 1 Comment
Insiders Love These 3 Highly Shorted Biotech Stocks
Kapitall • Tue, Jan 8 • 1 Comment
Insider Buying Trends: Are These Cash Rich Companies Ready To Rally?
Kapitall • Fri, Jan 4
5 Stocks With Unusual Volume
Mike King • Thu, Dec 13, 2012
3 Biotechs Racing Higher On Positive Developments
Heisenberg Principle • Tue, Dec 11, 2012 • 6 Comments
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Kapitall • Fri, Nov 30, 2012
Contrarian Ideas: 7 Stocks On Winning Streaks With Significant Short Increases
Kapitall • Tue, Oct 2, 2012 • 3 Comments
Top 5 Insider Buys Filed On September 11
Markus Aarnio • Wed, Sep 12, 2012 • 5 Comments

Infinity to Present at Deutsche Bank's 38th Annual Health Care Conference

Business Wire (Wed, 8:00AM)
Infinity Announces Clinical Data to Be Presented at ASCO and ICML

Business Wire (May 15, 2013)
Infinity to Present at the UBS Global Healthcare Conference

Business Wire (May 14, 2013)
Infinity Reports First Quarter 2013 Financial Results and Provides Company Update

Business Wire (May 7, 2013)
Infinity Announces the Date of Its First Quarter 2013 Financial Results Conference Call and Webcast

Business Wire (Apr 24, 2013)
Infinity to Present at the Needham 12th Annual Healthcare Conference

Business Wire (Apr 23, 2013)
Infinity Announces Closing of Secondary Offering of Common Stock and Exercise of Over-Allotment Option

Business Wire (Apr 16, 2013)
Infinity Announces Pricing of Secondary Offering of Common Stock

Business Wire (Apr 11, 2013)
Infinity Announces Proposed Secondary Offering of Common Stock

Business Wire (Apr 9, 2013)
Infinity to Present at the 25th Annual Roth Conference

Business Wire (Mar 11, 2013)
Infinity Provides Company Update and Reports Full-Year 2012 Financial Results

Business Wire (Mar 5, 2013)
Infinity to Present at Upcoming Conferences

Business Wire (Feb 25, 2013)
Infinity Announces the Date of Its Full-Year 2012 Financial Results Conference Call and Webcast

Business Wire (Feb 19, 2013)
Infinity to Participate in Three Conferences in February

Business Wire (Feb 6, 2013)
Infinity Provides Key 2013 Goals and Financial Guidance

Business Wire (Jan 7, 2013)
Infinity to Present at the J.P. Morgan Annual Healthcare Conference

Business Wire (Dec 31, 2012)
Infinity Amends PI3K-Delta,Gamma Agreement with Millennium

Business Wire (Dec 24, 2012)
Infinity Announces Closing of Public Offering and Exercise of Over-Allotment Option

Business Wire (Dec 18, 2012)
Infinity Prices Public Offering of Common Stock

Business Wire (Dec 13, 2012)
Infinity Announces Proposed Public Offering of Common Stock

Business Wire (Dec 12, 2012)

INFI vs. ETF Alternatives

Company Description

Currently, there's no company description for INFI.

Sector: Services

Industry: Research Services

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 16, 1:39 PM Infinity Pharmaceuticals (INFI -20.5%) gets slammed by cautious comments out of JPMorgan today, saying that investors are "growing increasingly skittish" ahead of INFI's pending presentation at June's ASCO cancer conference. The company is expected to release Phase 1 clinical safety and tolerability data for IPI-145, its experimental leukemia drug, and while the investment bank predicts "a good showing," it may not be enough to outshine Gilead (GILD -2.3%), Pharmacyclics (PCYC -2.5%) or Roche (RHHBY.OB -0.6%). 3 Comments [Healthcare, On the Move]
Thursday, May 16, 12:51 PM Midday top 10 gainers: EGLE +46%. NBG +24%. SBSA +23%. DQ +22%. GNK +19%. AEGR +19%. GLBS +17%. SINO +17%. PRGN +16%. LWAY +16%.
Midday top 10 losers: NCT -54%. SNFCA -22%. ONTY -21%. INFI -19%. CNIT -15%. CYCC -14%. PTSX -14%. AMD -13%. BDCO -11%. TRIT -11%. 2 Comments [On the Move]
Tuesday, May 7, 8:04 PM Infinity Pharmaceuticals (INFI): Q1 EPS of -$0.57 beats by $0.10. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 11, 8:28 AM Infinity Pharmaceuticals (INFI) heads lower in early trading as the company prices its previously announced secondary offering at $40 per share. Shares -3.24% premarket after falling -9% Wednesday. Comment! [Healthcare, On the Move]
Tuesday, April 9, 5:19 PM Infinity Pharmaceuticals (INFI) loses ground after announcing a non-dilutive public offering of 8.5M shares. Beacon and Rosebay and Purdue Pharma are the selling shareholders, offering 4.25M common units each. Shares -2.75% AH. Comment! [Healthcare, On the Move]
Tuesday, March 5, 4:32 PM Infinity Pharmaceuticals (INFI): Q4 EPS of -$1.15 misses by $0.28. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, February 19, 10:02 AM Infinity Pharmaceuticals (INFI) +8.6% after Morgan Stanley initiates coverage with an Overweight rating and a price-target of $47. "Infinity's wholly-owned early stage IPI-145 for blood cancers has shown positive early data and is on track to figure significantly in an emerging BCR drug class with multi-billion dollar potential. 2013 holds multiple catalysts to further validate IPI-145's efficacy/safety," firm says. Comment! [On the Move, Healthcare]
Thursday, December 13, 2012, 11:45 AM Infinity Pharmaceuticals (INFI +8.1%) moves higher today after high demand for the shares put the price on its 5.7M share secondary offering at $26.33, flat with Wednesday's close. The company says it intends to use the funds for R&D costs, potential acquisitions and other purposes. Comment! [Healthcare, On the Move]
Wednesday, November 21, 2012, 12:45 PM Midday top 10 gainers: MEMS +72%. NLP +38%. ARCI +20%. INFI +14%. VVUS +14%. NCTY +13%. SKX +12%. SQNM +11%. PSUN +11%. MTSL +11%. Midday top 10 Losers: STV -46%. ZLC -29%. CNET -18%. SCHL -18%. TLYS -17%. STJ -14%. CLNT -13%. EBR -11%. HGSH -11%. KID -11%. 1 Comment [On the Move]
Monday, November 12, 2012, 5:45 PM After-hours top gainers, as of 5:15 p.m.: SNTA +19.8%. IQNT +18.7%. LPH +10.2%. TSPT +8.9%. CSOD +8.1%.
After-hours top losers: INFI -8.6%. SCLN -5.5%. EVER -4.4%. GME -4.1%. MWE -3.7%. Comment! [On the Move]
Thursday, August 9, 2012, 12:40 PM Infinity Pharmaceuticals (INFI +2.2%) sluffs off pressure from pricing its 5.3M share offering earlier this morning to trade higher. Shares priced at $14.50, a 4.4% discount to Wednesday's close. The stock has been a resilient performer, surging over 84% in the past 12 months. Comment! [Healthcare, On the Move]
Wednesday, July 18, 2012, 9:10 AM Infinity Pharmaceuticals (INFI) -8.1% premarket after it terminates agreements with Mundipharma and Purdue Pharmaceutical Products. With this restructuring, INFI regains worldwide rights for its PI3K, FAAH and early discovery programs, and Mundipharma will no longer provide R&D funding to the company. Comment! [Healthcare, On the Move]
Monday, June 18, 2012, 9:05 AM Premarket gainers: XG +53%. ELT +19%. BVSN +6%.
Losers: BODY -30%. INFI -16%. DSW -9%. ING -5%. Comment! [On the Move]
Monday, June 18, 2012, 8:16 AM Infinity Pharmaceuticals (INFI) -20% after saying it's ending Phase 2 studies of its saridegib drug for treating bone and cartilage cancers due to disappointing results. It's another blow for Infinity with saridegib, which failed trials for pancreatic cancer earlier this year. Infinity has a cash runway until 2014 and will update its 2012 guidance in August. Comment! [Healthcare, On the Move]
Friday, January 27, 2012, 8:30 AM Infinity Pharmaceuticals (INFI) ends a mid-stage trial of its pancreatic cancer treatment after results showed the drug wouldn't meet its primary goal. Shares of INFI are in a freefall, down 44.9% premarket. Comment! [On the Move, Healthcare]
Tuesday, July 12, 2011, 3:48 PM Shares of Infinity Pharmaceuticals (INFI +9.6%) pop on above-average volume as the company expands its program to develop new cancer drugs, buying nuisance weeds in western states, unwanted by landowners, but needed by the firm. Comment! [On the Move, Healthcare]

Jason F
$UNXL Trading plan + Charts: http://bit.ly/12TgCcG check it out. I've made gr8 calls on $INFI $SCTY $TSLA recently.
Tue, 2:30 PM
Reply (16)

• !Report Abuse
View all 16 replies
Jason F: thanks
Tue, 5:45 PM
• !Report Abuse
Jason F: we up 7% on $UNXL already unloaded half my position. i am 1 for 1 on UNXL
Wed, 9:36 AM
• !Report Abuse
Add a reply...

140 characters

Kapitall
Insiders And Funds Are Bullish On These 3 Small Cap Healthcare Stocks $AEGR $INFI $PACB http://bit.ly/ZaYWvQ
Tue, 1:03 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jason F
An incredible risk to reward setup: $INFI game plan is here: http://bit.ly/13zrZIP
May 16, 2:01 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Returning Downgrades (5/1/13): $FAST, $FLS, $GVA, $H, $INFI, $IR, $JBHT, $KAMN, $LII, $LMNX, $MHK, $MLHR, $MSCI, $MTW, $MWV
May 2, 10:30 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Potential Downgrades (4/4/13): $EFX, $EOG, $EPB, $EPD, $FIRE, $FISV, $FXY, $GBX, $HAIN, $HES, $HIBB, $HTZ, $HURN, $IBN, $INDL, $INFI, $INFY
Apr 5, 12:45 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
New Upgrades (4/2/13): $AMT, $APO, $BNO, $HRS, $INFI, $LTD, $PSA, $SVXY, $TU, $URBN, $ZMH
Apr 3, 1:02 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Potential Upgrades (3/27/13): $AMZN, $ATHN, $BIDU, $EQIX, $ESV, $INFI, $MON, $NSM, $NSR, $OCN, $SCSS, $UTHR, $VPHM, $WCG
Mar 28, 10:07 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

StockConsultant
$INFI breakout watch above 14.5
Mar 1, 10:38 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Tony Kau
Just closed 5d holds: $NILE short +2.7% $FDO long +.7% $INFI short -2.6% $DMND long -7.4% for a rough day... http://bit.ly/HDM3RA
4/13/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Tony Kau
TrendExhaustionPRO live SELLS: $AAPL $TLT $CNS $PSMT $LQDT $INFI $GEO $PCLN $HGIC $VVUS http://bit.ly/HbSeYM
4/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

INFI Infinity Pharmaceuticals, Inc.

INFI

Infinity Pharmaceuticals, Inc.